Charles River Q4 revenue $1.10B (+21.5% YoY); DOJ subpoena on NHP supply; 2023 guidance below expectations

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

2022-FY EPS reported $9.48 revenue$3,976,060,000

Q4 GAAP EPS $3.65, non-GAAP EPS $2.98; full-year GAAP EPS $9.48, non-GAAP EPS $11.12.
Q4 organic revenue growth 18.8% led by DSA segment (+26.5% organic).
Received DOJ subpoena on Cambodian NHP supply chain; voluntarily suspended shipments from Cambodia.
2023 guidance: reported revenue growth 1.5%-4.5%, organic 4.5%-7.5%; GAAP EPS $7.40-$8.60, non-GAAP $9.70-$10.90.
NHP supply constraints expected to reduce 2023 revenue growth by 200-400 bps; higher tax and interest to pressure EPS.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. reported Fourth Quarter 2022 results: revenue $1.10 Billion, net income $187.4 million, EPS $3.65.

Period: Fourth Quarter 2022
Revenue: $1.10 Billion
Net income: $187.4 million
EPS: $3.65
Result: reported results

Exact text from the filing

EXHIBIT 99.1 Exhibit 99.1 Charles River Laboratories Announces Fourth-Quarter and Full-Year 2022 Results and Provides 2023 Guidance – Fourth-Quarter Revenue of $1.10 Billion and Full-Year Revenue of $3.98 Billion – – Fourth-Quarter GAAP Earnings per Share of $3.65 and Non-GAAP Earnings per Share of $2.98 – – Full-Year GAAP Earnings per Share of $9.48

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. reported Full Year 2022 results: revenue $3.98 Billion, EPS $9.48.

Period: Full Year 2022
Revenue: $3.98 Billion
EPS: $9.48
Result: reported results

Exact text from the filing

Charles River Laboratories Announces Fourth-Quarter and Full-Year 2022 Results and Provides 2023 Guidance – Fourth-Quarter Revenue of $1.10 Billion and Full-Year Revenue of $3.98 Billion – – Fourth-Quarter GAAP Earnings per Share of $3.65 and Non-GAAP Earnings per Share of $2.98 – – Full-Year GAAP Earnings per Share of $9.48 and Non-GAAP Earnings per Share of $11.12 – – Provides 2023 Guidance –

View on SEC.gov

39 earnings releases filed in the last 30 days. Browse all earnings releases →

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. filing history →

Source: SEC EDGAR

accession 0001157523-23-000326

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.